Trials / Completed
CompletedNCT02078856
Double-blind, Randomised Study of A3384 in BAM/BAD
A Phase II, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of A3384 in Patients With Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Albireo · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A3384 |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-03-05
- Last updated
- 2024-03-07
Locations
3 sites across 2 countries: Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02078856. Inclusion in this directory is not an endorsement.